3-[(E)-2-丁酰基]-1,3-噁唑烷-2-酮 | 109299-92-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 中文名称: 3-[(E)-2-丁酰基]-1,3-噁唑烷-2-酮
• 英文名称: 3-((E)-but-2-enoyl)oxazolidin-2-one
• 英文别名: 3-Crotonoyl-2-oxazolidinone；(E)-3-(but-2-enoyl)oxazolidin-2-one；3-[(E)-2-Butenoyl]-1,3-oxazolidin-2-one；3-[(E)-but-2-enoyl]-1,3-oxazolidin-2-one
• CAS: 109299-92-5
• 化学式: C₇H₉NO₃
• 分子量: 155.153
• InChiKey: PNPVETUIPHVXGI-NSCUHMNNSA-N

物化性质

• 熔点：
  37-41 °C
• 沸点：
  278.94°C (rough estimate)
• 密度：
  1.3004 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2934999090

SDS

Name:	3-[(E)-2-Butenoyl]-1 3-oxazolidin-2-one 99% Material Safety Data Sheet
Synonym:
CAS:	109299-92-5

Section 1 - Chemical Product MSDS Name:3-[(E)-2-Butenoyl]-1 3-oxazolidin-2-one 99% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
109299-92-5	3-[(E)-2-Butenoyl]-1,3-oxazolidin-2-on	99%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Keep refrigerated. (Store below 4C/39F.) Store under nitrogen.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 109299-92-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: off-white - light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 37.00 - 41.00
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H9NO3
Molecular Weight: 155.0679

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 109299-92-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-[(E)-2-Butenoyl]-1,3-oxazolidin-2-one - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 109299-92-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 109299-92-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 109299-92-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-[(E)-2-丁酰基]-1,3-噁唑烷-2-酮 在 (2,2-bis[2-[4(S)-tertbutyl-1,3-oxazolinyl]]propane)CuCl₂ silver hexafluoroantimonate 、 六氟异丙醇 、 三氯化硼 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 反应 0.83h， 生成
  参考文献：
  名称：

  双(恶唑啉)铜(II)配合物催化的对映选择性和非对映选择性Mukaiyama-Michael反应

  摘要：

  使用 [Cu((S,S)-t-Bu-box)](SbF6)2 (1a) 作为路易斯酸催化剂，开发了烯醇硅烷对不饱和酰亚胺衍生物的高度对映选择性和非对映选择性迈克尔加成的范围。这些添加的产物是有用的合成子，包含能够在温和条件下分化的末端。迈克尔受体 pi 面选择性与酰亚胺底物的两点结合一致，可以看作是相应 Diels-Alder 反应中底物对映选择的延伸。提出了一种类似于用于描述异狄尔斯-阿尔德反应的模型来解释烯醇硅烷几何形状与产物绝对非对映控制之间的观察关系。给出了对催化剂失活模式的见解，包括在反应过程中产生的二氢吡喃中间体抑制催化剂的光谱证据。公开了一种方法，其中使用醇添加剂水解抑制性二氢吡喃并在显着缩短的反应时间内提供去甲硅烷基化的迈克尔加合物。

  DOI：

  10.1021/ja010302g
• 作为产物：
  描述：

  3-butyryloxazolidin-2-one 在 正丁基锂 、 N-叔丁基苯硫腈氯化物 、 二异丙胺 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 0.5h， 以78%的产率得到3-[(E)-2-丁酰基]-1,3-噁唑烷-2-酮
  参考文献：
  名称：

  在温和条件下将羧酸衍生物一锅式脱氢为α，β-不饱和羰基化合物

  摘要：

  仅通过处理它们的烯醇锂，即可在-78°C下以锅法将N-酰基-2-恶唑烷酮，δ-内酯和δ-内酰胺等羧酸衍生物平稳脱氢为相应的α，β-不饱和羰基化合物。与ñ -叔-butylbenzenesulfinimidoyl酰氯。

  DOI：

  10.1016/j.tetlet.2004.11.106

文献信息

• Highly Diastereoselective Crown Ether Catalyzed Arylogous Michael Reaction of 3-Aryl Phthalides
  作者：Marina Sicignano、Antonella Dentoni Litta、Rosaria Schettini、Francesco De Riccardis、Giovanni Pierri、Consiglia Tedesco、Irene Izzo、Giorgio Della Sala

  DOI：10.1021/acs.orglett.7b02113

  日期：2017.8.18

  The first arylogous Michael reaction of 3-aryl phthalides has been developed. The reaction, promoted by catalytic amounts of KOH or K3PO4 and dibenzo-18-crown-6, affords the corresponding 3,3-disubstituted phthalides in good to high yields and as single diastereomers in nearly all studied cases.

  已经开发了第一个3-芳基邻苯二甲酸酯的迈克尔反应。由催化量的KOH或K 3 PO 4和二苯并18-冠-6促进的反应，以几乎所有的研究情况，均以高收率和高收率提供了相应的3,3-二取代邻苯二甲酸酯。
• Regio and diastereoselective multicomponent 1,3-dipolar cycloadditions between prolinate hydrochlorides, aldehydes and dipolarophiles for the direct synthesis of pyrrolizidines
  作者：Juan Mancebo-Aracil、Carmen Nájera、Luis M. Castelló、José M. Sansano、Olatz Larrañaga、Abel de Cózar、Fernando P. Cossío

  DOI：10.1016/j.tet.2015.10.064

  日期：2015.12

  adducts 2,4-trans-2,5-trans according to an endo-approach and a S-dipole geometry of the in situ generated azomethine ylide. For proline esters a similar regioselectivity and endo-diastereoselectivity are observed when the dipole promotes an α-attack. However, when ethyl glyoxylate is used as aldehyde component the γ-attack of the S-ylide takes place preferentially giving rise the opposite regioselectivity

  可以在室温下无催化剂或在AgOAc（5 mol％）存在的情况下，使用脯氨酸酯盐酸盐，醛和双极性亲和剂，通过多组分1,3-偶极环加成反应进行高度取代的吡咯嗪核苷的一般合成。在（2 S，4 R）-4-羟基脯氨酸衍生物的情况下，有可能获得对映体富集的吡咯烷核苷，其对区域和非对映体选择性的控制较高，从而根据内含物提供2,4-反式-2,5-反式加合物-方法和原位产生的甲亚胺叶立德的S-偶极几何形状。对于脯氨酸酯，具有相似的区域选择性和内切当偶极子促进α攻击时，观察到-非对映选择性。然而，当乙醛酸乙酯用作醛组分时，S-内酯的γ-攻击优先发生，从而引起对丙烯酸类双极性亲和剂的相反的区域选择性，这是乙酸银的关键作用。在这种情况下，外与2,3- -adducts顺-2,5-反式均非对映选择性得到相对构型。另外，还进行了计算研究以阐明对于所述的1，3-偶极环加成反应观察到的非对映选择性和区域选择性的起源。
• Visible light photocatalytic asymmetric synthesis of pyrrolo[1,2-<i>a</i>]indoles <i>via</i> intermolecular [3+2] cycloaddition
  作者：Antonio Casado-Sánchez、Pablo Domingo-Legarda、Silvia Cabrera、José Alemán

  DOI：10.1039/c9cc05838a

  日期：——

  The intermolecular diastereoselective and enantioselective synthesis of pyrrolo[1,2-a]indoles is developed through a [3+2] cycloaddition between silyl-indole derivatives and α,β-unsaturated N-acyl oxazolidinones by merging photocatalysis and Lewis acid catalysis.

  吡咯并[1,2- a ]吲哚的分子间非对映选择性和对映选择性合成是通过甲硅烷基吲哚衍生物与α，β-不饱和N-酰基恶唑烷酮通过光催化和路易斯酸催化的[3 + 2]环加成反应而开发的。
• Rational Design of Highly Diastereoselective, Organic Base-Catalyzed, Room-Temperature Michael Addition Reactions¹
  作者：Vadim A. Soloshonok、Chaozhong Cai、Victor J. Hruby、Luc Van Meervelt、Takashi Yamazaki

  DOI：10.1021/jo0008791

  日期：2000.10.1

  homogeneity and high reactivity. The corresponding Michael addition reactions were found to proceed at room temperature in the presence of catalytic amounts of DBU to afford quantitatively the addition products with virtually complete diastereoselectivity. Acidic decomposition of the products followed by treatment of the reaction mixture with NH4OH gave rise to the diastereomerically pure 3-substituted

  通过合理设计单首选过渡态，并通过电子供体-受体型吸引相互作用使其稳定，已确定了相应起始化合物的结构和几何要求。甘氨酸的席夫碱与邻-​​[N-α-吡啶甲基氨基]苯乙酮（作为亲核甘氨酸等效物）和N-（反式-烯酰基）恶唑烷-2-酮（作为α的衍生物）的Ni（II）配合物，发现β-不饱和羧酸是具有几何/构象均质性和高反应性的选择底物。发现相应的迈克尔加成反应在室温下在催化量的DBU存在下进行，以定量提供具有几乎完全非对映选择性的加成产物。
• Improvement of TADDOLate−TiCl₂-Catalyzed 1,3-Dipolar Nitrone Cycloaddition Reactions by Substitution of the Oxazolidinone Auxiliary of the Alkene with Succinimide
  作者：Kim B. Jensen、Kurt V. Gothelf、Rita G. Hazell、Karl Anker Jørgensen

  DOI：10.1021/jo962214y

  日期：1997.4.1

  tested as catalysts for the 1,3-dipolar cycloaddition reactions, and the most successful catalyst was applied (5 mol %) in a series of reactions between two different alkenoylsuccinimides and three different nitrones. The crude products containing an N-acylsuccinimide moiety were converted directly into the corresponding carboxamides upon treatment with hydrazine. The 1,3-dipolar cycloaddition reactions

  使用琥珀酰亚胺作为α，β-不饱和羰基部分的新辅助剂，描述了金属催化的无环硝酮与α，β-不饱和羰基化合物的不对称1,3-偶极环加成反应的显着改进。在没有催化剂的情况下，N-巴豆酰琥珀酰亚胺与C，N-二苯基硝酮反应生成内异异唑烷，而在10 mol％TiCl（2）（i-PrO）（2）的存在下，获得了外切产物。已经测试了四种不同的TiCl（2）-TADDOLate配合物作为1,3-偶极环加成反应的催化剂，最成功的催化剂（5 mol％）被应用在两种不同的烯基琥珀酰亚胺和三种不同的硝酮之间的一系列反应中。在用肼处理后，将含有N-酰基琥珀酰亚胺部分的粗产物直接转化为相应的羧酰胺。1,3-偶极环加成反应以高的exo-选择度进行，通常> 90％de，与以前使用恶唑烷酮助剂进行烯酰基部分进行的实验相比，这是一个改进。此外，与先前的工作相比，对映选择性也得到了改善，并且获得了高达73％的ee，这是这些金属催化的exo-selected